In the present study, we examined the level amongst SKA2, SPRY4-IT1, and NT21MP, confirming SKA2 was the target gene of SPRY4-IT1, and the regulation of SPRY4-IT1 on biological activity in breast cancer cells was partially achieved through SKA2. The gene discussed is SPRY4; the disease is breast carcinoma.